News
Review the current Powersoft SpA Ordinary Shares (PWS:XMIL) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if PWS is the best investment for you.
Levo Therapeutics Announces Top-line Results from Ph. 3 CARE-PWS Study of LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results